Insider Shareholders with Direct Ownership of Harmony Biosciences Holdings, Inc. (HRMY)
This section provides a comprehensive overview of the insiders with direct ownership of Harmony Biosciences Holdings, Inc. (HRMY). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Harmony Biosciences Holdings, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Valor Iv Pharma Holdings, Llc
> 10% Shareholder |
0 | 4,600,000 | 6,618,033 $225 Million | 2 |
Nov 05, 2024
Reduced 8.31%
|
|
Marshman Fund Trust Ii
> 10% Shareholder |
339,476 | 4,600,000 | 6,051,120 $206 Million | 3 |
Nov 05, 2024
Reduced 9.02%
|
|
Novo Holdings
> 10% Shareholder |
4,409,803 | 0 | 4,409,803 $150 Million | 1 |
Aug 21, 2020
Added 2.92%
|
|
Jeffrey S Aronin
Director |
251,922 | 0 | 251,922 $8.58 Million | 1 |
Dec 14, 2021
Added 50.0%
|
|
Sandip Kapadia
CHIEF FINANCIAL OFFICER |
105,000 | 55,479 | 27,948 $951,908 | 6 |
Sep 30, 2024
Reduced 53.42%
|
|
John C Jacobs
PRESIDENT, CEO |
200,000 | 200,000 | 0 $0 | 20 |
Aug 15, 2022
Reduced 100.0%
|
|
Jeffrey Dierks
CHIEF COMMERCIAL OFFICER |
256,224 | 260,283 | 0 $0 | 41 |
Oct 29, 2024
Reduced 100.0%
|
|
Jeffrey M. Dayno
PRESIDENT, CEO |
80,000 | 80,000 | 0 $0 | 18 |
Nov 03, 2022
Reduced 100.0%
|
|
Andrew Serafin
CHIEF STRATEGY OFFICER |
38,000 | 38,000 | 0 $0 | 2 |
Dec 02, 2022
Reduced 100.0%
|